The understanding of narcolepsy has been enhanced by neurophysiologic
investigations in humans and by pharmacologic and biochemical studies
using the canine model of narcolepsy. Repetitive microsleeps have a mo
re deleterious effect on performance than several short complete naps
during the day. Under normal living conditions, the nocturnal sleep of
narcoleptic patients is disrupted, and the spectral analysis of centr
al EEG leads shows less delta power density per epoch than it does in
age-matched controls, who have an absence or decrease of the usual dec
ay in delta power across the night. Cataplexy is associated with a dro
p in H-reflex, even during partial cataplectic attacks. Monitoring of
heart rate and intra-arterial blood pressure during cataplexy in human
s shows a decrease in heart rate and an increase-in blood pressure wit
h onset of cataplexy, but the change in heart rate is secondary to the
change in blood pressure. Investigations of narcoleptic Doberman pins
chers have implicated several neurotransmitters in the brainstem and a
mygdala. In vivo dialysis and in situ injections of carbachol indicate
that the pontine reticular formation is not the only muscarinic choli
nergic region involved, but data support the existence of a multisynap
tic descending pathway involved in the muscle atonia of cataplexy. Car
bachol injections into the basal forebrain induce status cataplecticus
. Experimental findings suggest a hypersensitivity of the overall musc
arinic cholinergic system and that this hypersensitive cholinergic sys
tem is linked to the limbic system. An increase in the postsynaptic D-
2 dopaminergic receptor is observed in the amygdala of narcoleptic dog
s compared with controls, with impairment of dopamine release. The ass
ociated findings suggest that an abnormal cholinergic-dopaminergic int
eraction could underlie the pathophysiology of narcolepsy.